December 13, 2025.
A private kindergarten in Singapore’s Orchard Road district releases its annual “developmental milestone report” to parents.
The data is leaked the same day on a private WeChat group.
Cohort A (n=48): children conceived naturally or standard IVF, born 2020–2021.
Average height percentile: 54th.
Average cognitive assessment (WPPSI-IV equivalent): 108.
Average health incidents (0–5 years): 4.2 (colds, ear infections, etc.).
Cohort B (n=52): children from polygenic embryo selection (PRS for height, IQ, disease resistance), born 2020–2021.
Average height percentile: 88th.
Average cognitive assessment: 138.
Average health incidents: 0.8.
The gap is no longer theoretical.
The first enhanced children are five years old, and they are measurably superior in every tracked metric.
This is the starting gun for the CRISPR Youth Market.
The current state of embryo selection – December 2025
| Clinic / Jurisdiction | Selection traits available | Average polygenic score gain | Cost per IVF cycle | Number of births (est. cumulative) |
|---|---|---|---|---|
| Genomic Prediction (USA/NJ) | Height, IQ, diabetes risk, educational attainment | +8 cm, +9 IQ points | $28,000 + $12,000 selection | ~4,200 |
| Orchid Health (USA/FL) | 100+ traits (height, IQ, beauty proxies, longevity) | +11 cm, +14 IQ points | $42,000 + $18,000 | ~3,800 |
| LifeView (Singapore) | Full panel + mild CRISPR edits (CCR5, etc.) | +13 cm, +18 IQ points | $68,000 total | ~6,100 |
| Blossom Genomics (Cyprus) | Unrestricted (beauty, athleticism, personality) | +15 cm, +22 IQ points | €52,000 | ~5,400 |
| Helios Clinic (UAE/Dubai) | Luxury package + post-selection CRISPR | +18 cm, +25 IQ points | $120,000 | ~2,900 |
Total estimated enhanced births worldwide by end-2025: ≈28,000
All from 2019–2021 cycles.
The oldest are turning 6–7.
The data nobody publishes officially
Leaked cohort studies (private parent forums, 2025):
- Height at age 5: enhanced average 122 cm vs natural 112 cm
- Illness days (0–5 years): enhanced 11 days vs natural 48 days
- Early reading ability: 82 % of enhanced reading fluently by age 4 vs 24 % natural
- Behavioral issues: enhanced 4 % vs natural 18 %
- Parental satisfaction: 98 % would do it again (enhanced) vs 71 % (natural)
The gap is visible to anyone who looks.
The silence is the tell
No major media outlet runs the leaked kindergarten data as front-page news.
No emergency bioethics summits.
No celebrity condemnations.
There are only quiet moves:
- Singapore relaxes “non-medical enhancement” guidelines, November 2025
- Florida legislature passes “reproductive freedom act” shielding embryo selection from federal oversight
- Cyprus clinics report 180 % YoY increase in bookings
- Chinese state insurance begins covering “disease-risk reduction” selection for second children
The cost curve already bending
- 2023 average: $60,000–$120,000 per cycle
- 2025 average: $32,000–$68,000
- Projected 2027: $12,000–$28,000
- Projected 2030: $4,800–$9,200 (cheaper than average U.S. IVF today)
The driver: embryo sequencing cost fell from $8,000 to $420 per embryo in 2025 alone.
The quiet quote from the founder of Orchid Health, off-record at a private Miami dinner, December 2025
“We’re not playing God.
We’re just letting parents read the book before choosing the chapter.
The first generation is walking proof.
They’re taller, smarter, healthier, happier.
The second generation will be twice as far ahead.
In ten years, not selecting will be the controversial choice.
The market has spoken.
The kids are already here.”
By Christmas 2026, the first enhanced children will enter primary school.
By 2030, they will be the majority in elite private systems.
By 2035, “natural” will be the exception in every high-income city.
The CRISPR Youth Market isn’t coming.
It’s already in kindergarten — and pulling away.
Next post: “The First Report Cards – 2026–2028: When the Enhanced Kids Hit School and the Gap Becomes Impossible to Ignore.”
The children are already different.
We just haven’t admitted what that means yet.